Android app on Google Play

Citi Upgrades Biogen (BIIB) to Buy

February 8, 2013 6:53 AM EST Send to a Friend
Get Alerts BIIB Hot Sheet
Price: $343.04 +0.53%

Rating Summary:
    21 Buy, 7 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 3 | Down: 4 | New: 7
Trade BIIB Now!
Join SI Premium – FREE
Citi upgraded Biogen (NASDAQ: BIIB) from Neutral to Buy with a price target of $187.00 (from $160.00).

For an analyst ratings summary and ratings history on Biogen click here. For more ratings news on Biogen click here.

Shares of Biogen closed at $160.30 yesterday.




You May Also Be Interested In


Related Categories

Analyst PT Change, Upgrades

Related Entities

Citi

Add Your Comment